Your browser doesn't support javascript.
loading
Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).
Yoon, Sun A; Han, Byoung G; Kim, Sung G; Han, Sang Y; Jo, Young I; Jeong, Kyung H; Oh, Kook H; Park, Hyeong C; Park, Sun H; Kang, Shin W; Na, Ki R; Kang, Sun W; Kim, Nam H; Jang, Young H; Shin, Seong H; Cha, Dae R.
Afiliação
  • Yoon SA; Department of Internal Medicine, Catholic University Uijeongbu St. Mary's Hospital, Uijeongbu, Republic of Korea.
  • Han BG; Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  • Kim SG; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.
  • Han SY; Department of Internal Medicine, Inje University, Ilsan Paik Hospital, Goyang, Republic of Korea
  • Jo YI; Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Republic of Korea.
  • Jeong KH; Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
  • Oh KH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Park HC; Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Republic of Korea.
  • Park SH; Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea.
  • Na KR; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea.
  • Kang SW; Department of Internal Medicine, Busan Paik Hospital, Busan, Republic of Korea.
  • Kim NH; Department of Internal Medicine, Chonnam National University College of Medicine, Gwangju, Republic of Korea.
  • Jang YH; LG Life Sciences, Seoul, Republic of Korea.
  • Shin SH; LG Life Sciences, Seoul, Republic of Korea.
  • Cha DR; Korea University Ansan-Hospital, Ansan, Republic of Korea.
Diabetes Obes Metab ; 19(4): 590-598, 2017 04.
Article em En | MEDLINE | ID: mdl-28019072
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidonas / Pirimidinas / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Albuminúria / Hipoglicemiantes Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2017 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidonas / Pirimidinas / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Albuminúria / Hipoglicemiantes Tipo de estudo: Clinical_trials / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2017 Tipo de documento: Article País de publicação: Reino Unido